These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8746127)

  • 1. Deleterious effects of prostaglandin E2 in reflux oesophagitis.
    Morgan G
    Med Hypotheses; 1996 Jan; 46(1):42-4. PubMed ID: 8746127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleterious effects of prostaglandin E2 in oesophageal carcinogenesis.
    Morgan G
    Med Hypotheses; 1997 Feb; 48(2):177-81. PubMed ID: 9076700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs and the oesophagus.
    Mason JC
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):369-73. PubMed ID: 10321751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
    Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
    Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A brief review of recent achievements concerning biochemistry and physiology of prostaglandins in the eye].
    Kahán LI; Dekov AM; Pálfalvi M; Imre G
    Orv Hetil; 1999 Nov; 140(48):2685-9. PubMed ID: 10645713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of reflux peptic esophagitis: literature review].
    Van Gossum M
    Rev Med Brux; 1994; 15(1):20-4. PubMed ID: 7910701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis.
    Frazzoni M; Bertani H; Manta R; Mirante VG; Frazzoni L; Conigliaro R; Melotti G
    Dig Liver Dis; 2014 Jul; 46(7):596-602. PubMed ID: 24709005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental oesophagitis in the rat is associated with decreased voluntary movement.
    Miwa H; Oshima T; Sakurai J; Tomita T; Matsumoto T; Iizuka S; Koseki J
    Neurogastroenterol Motil; 2009 Mar; 21(3):296-303. PubMed ID: 19126182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CCl4 and blocking H2S biosynthesis on oesophageal mucosa rats: model of nonerosive oesophagitis.
    Khyrivska D; Hrytsevych N; Bula N; Pshyk-Titko I; Savytska M; Zayachkivska O; Havryluk E
    Folia Med Cracov; 2014; 54(4):79-90. PubMed ID: 25891244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model.
    Poplawski C; Sosnowski D; Szaflarska-Popławska A; Sarosiek J; McCallum R; Bartuzi Z
    World J Gastroenterol; 2006 Mar; 12(11):1739-42. PubMed ID: 16586543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression.
    Ota S; Tanaka Y; Bamba H; Kato A; Matsuzaki F
    Eur J Pharmacol; 1999 Feb; 367(1):131-8. PubMed ID: 10082276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic oesophagitis in the cat.
    Poorkhalkali N; Rich HG; Jacobson I; Amaral J; Migliori S; Chrostek C; Biancani P; Cabero JL; Helander HF
    Scand J Gastroenterol; 2001 Sep; 36(9):904-9. PubMed ID: 11521978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on "impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602].
    Savarino E; Marabotto E; Bartolo O; de Cassan C
    Dig Liver Dis; 2014 Nov; 46(11):1052. PubMed ID: 25081845
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins and the pathophysiology of esophagitis.
    Rigas B
    J Clin Gastroenterol; 1995 Dec; 21(4):266-7. PubMed ID: 8583096
    [No Abstract]   [Full Text] [Related]  

  • 18. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins in the treatment of reflux oesophagitis: double-blind placebo controlled clinical trial.
    Purushotham AD; Gray GR; Hansell DT
    J R Coll Surg Edinb; 1991 Aug; 36(4):216-8. PubMed ID: 1941733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acid on the motility of the oesophagus of the pig with experimentally induced oesophagitis.
    Punto L; Koivisto E
    Scand J Gastroenterol; 1977; 12(7):775-80. PubMed ID: 594648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.